奥浦迈9月1日获融资买入1318.29万元，融资余额5756.19万元

Core Viewpoint - Aopu Mai has shown a stable financial performance with significant growth in revenue and net profit, while its financing activities indicate a low level of leverage and a high level of short selling activity [1][2][3]. Financial Performance - For the first half of 2025, Aopu Mai achieved operating revenue of 178 million yuan, representing a year-on-year growth of 23.77% [2]. - The net profit attributable to the parent company was 37.55 million yuan, reflecting a year-on-year increase of 55.55% [2]. Shareholder and Market Activity - As of June 30, 2025, the number of Aopu Mai shareholders increased to 3,212, up by 6.11% from the previous period [2]. - The average number of circulating shares per shareholder decreased by 5.76% to 24,100 shares [2]. - Aopu Mai has distributed a total of 147 million yuan in dividends since its A-share listing [3]. Financing and Margin Trading - On September 1, Aopu Mai recorded a financing buy amount of 13.18 million yuan and a financing repayment of 14.20 million yuan, resulting in a net financing buy of -1.02 million yuan [1]. - The total margin trading balance for Aopu Mai was 57.56 million yuan, accounting for 1.38% of its market capitalization, which is below the 20th percentile level over the past year, indicating a low leverage position [1]. - In terms of short selling, Aopu Mai had no shares sold or repaid on September 1, with a short selling balance of 0 shares, which is above the 70th percentile level over the past year, indicating a high level of short selling activity [1]. Institutional Holdings - As of June 30, 2025, among the top ten circulating shareholders, ICBC Frontier Medical Stock A held 2.90 million shares, an increase of 1.25 million shares from the previous period [3]. - Other notable institutional shareholders include China Merchants Medical Health Industry Stock and a new entrant, China Europe Medical Health Mixed A, which held 1.48 million shares [3].